Systems based medication governance: Empowering pharmacists in strategic policy, compliance and health outcomes leadership

The dynamic landscape of healthcare demands a transformative approach to medication governance—one that repositions pharmacists as integral leaders in shaping policy, ensuring compliance, and driving improved health outcomes. Systems-based medication governance offers a holistic and structured framework in which medication management is embedded within the broader context of health system performance, regulatory oversight, and clinical accountability. This paradigm empowers pharmacists not merely as dispensers of medication but as architects of therapeutic strategy, quality assurance, and population health interventions. This study explores the evolution and operationalization of systems-based medication governance, highlighting how pharmacists can lead within multidisciplinary care teams to influence national formularies, medication safety protocols, and real-time clinical decision support systems. Emphasis is placed on the intersection between policy-making, digital health integration, and performance-based compliance, where pharmacists act as stewards of both public health and institutional accountability. Through comparative case studies, stakeholder interviews, and policy analysis, the research investigates best practices in countries where pharmacist-led governance models have successfully contributed to reduced medication errors, cost containment, and improved therapeutic outcomes. The paper also examines challenges such as regulatory constraints, interprofessional resistance, and gaps in leadership training among pharmacists. Findings support a shift towards systems-oriented thinking in pharmaceutical services, advocating for strategic capacity-building, regulatory reform, and digital infrastructure that enables pharmacists to proactively manage clinical and policy-level medication risks. This work underscores the untapped leadership potential of pharmacists and calls for a systemic recalibration of their role within integrated health governance models.